SCHEMBL28000271

SCHEMBL28000271

CC(C)(C)OC(=O)Nc1cccc(CCC=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.48
CYP2C19 P33261 1/20 0.48
HDAC6 Q9UBN7 2/20 0.46
HDAC3 O15379 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC2 Q92769 1/20 0.46
HDAC8 Q9BY41 1/20 0.46
AURKA O14965 1/20 0.46
RPS6KB1 P23443 1/20 0.46
CYP17A1 P05093 2/20 0.46
SIRT2 Q8IXJ6 1/20 0.45
TLR7 Q9NYK1 1/20 0.42
GLS O94925 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
NPY1R P25929 1/20 0.42
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
PDK1 Q15118 1/20 0.40
PDK2 Q15119 1/20 0.40
PDK3 Q15120 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29420360 1.00 CYP3A4 (0.48) CYP3A4CYP2C19HDAC6HDAC3HDAC1
SCHEMBL694262 0.88 HDAC3 (0.49) CYP3A4CYP2C19HDAC6HDAC3HDAC1
SCHEMBL13801959 0.85 CYP3A4 (0.50) CYP3A4CYP2C19HDAC6HDAC3HDAC1
SCHEMBL27498370 0.85 CYP3A4 (0.50) CYP3A4CYP2C19HDAC6HDAC3HDAC1
SCHEMBL30844047 0.85 CYP3A4 (0.50) CYP3A4CYP2C19HDAC6HDAC3HDAC1
SCHEMBL13623152 0.85 CYP3A4 (0.50) CYP3A4CYP2C19HDAC6HDAC3HDAC1
SCHEMBL7156537 0.85 MGLL (0.52) CYP3A4CYP2C19AURKARPS6KB1SIRT2
SCHEMBL31370757 0.84 AURKA (0.50) CYP3A4CYP2C19HDAC6HDAC3HDAC1
SCHEMBL6965973 0.84 CYP3A4 (0.49) CYP3A4CYP2C19HDAC6HDAC3HDAC1
SCHEMBL13735759 0.84 CYP3A4 (0.49) CYP3A4CYP2C19HDAC6HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104470925-A Imidazotriazinecarbonitriles useful as kinase inhibitors BRISTOL MYERS SQUIBB CO 2015-03-25 CN disclosed